• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Goodrx Holdings Inc Cl A (NQ: GDRX )

    5.990 +0.120 (+2.04%)
    Streaming Delayed Price Updated: 2:24 PM EST, Nov 5, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Goodrx Holdings Inc Cl A

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    15 16 Next >
    SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in GoodRx Holdings, Inc. with Losses to Contact the Firm
    From Schall Law
    Via GlobeNewswire
    GOODRX HOLDINGS, INC. (NASDAQ: GDRX) INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against GoodRx Holdings, Inc.
    From Bernstein Liebhard LLP
    Via GlobeNewswire
    GDRX Alert: Rosen, Skilled Investor Counsel, Encourages GoodRx Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – GDRX
    From The Rosen Law Firm, P.A.
    Via Business Wire
    Why GoodRx Surged Today
    The prescription-drug upstart got an upgrade from Wall Street. 
    Via The Motley Fool
    The Latest Analyst Ratings For GoodRx Holdings
    Via Benzinga
    Earnings Scheduled For February 29, 2024
    Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million. 
    Via Benzinga
    GDRX INVESTOR ALERT: Kessler Topaz Meltzer & Check, LLP Files A Securities Fraud Class Action Lawsuit Against GoodRX Holdings, Inc. And Encourages Investors With Losses To Contact The Firm
    From Kessler Topaz Meltzer & Check, LLP
    Via Business Wire
    Wegovy vs. Zepbound: Who Wins the Battle of the GLP-1 Drugs?
    The GLP-1 weight loss trend continues to flourish, and the ante keeps rising; see how the winner between Wegovy and Zepbound can help your portfolio 
    Via MarketBeat
    GoodRx Announces Date for First Quarter 2024 Earnings Release and Conference Call
    From GoodRx Holdings, Inc.
    Via Business Wire
    In-Depth Examination Of 4 Analyst Recommendations For GoodRx Holdings
    Via Benzinga
    GoodRx Holdings Analyst Turns Bullish Ahead Of Q1 Earnings
    GoodRx Holdings Inc (NASDAQ: GDRX) got an upgrade last month from Wells Fargo analyst. 
    Via Benzinga
    Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Shares of Landos Biopharma, Inc. (NASDAQ: LABP) rose sharply during Monday’s session following acquisition news. 
    Via Benzinga
    Telemedicine GoodRx Has Potential To Excel, Close Valuation Gap By 2025, Analyst Says
    Wells Fargo's upgrade of GoodRx Holdings. Analysts anticipate strong revenue visibility and EBITDA margins, setting the stage for potential stock outperformance in 2024-2025. 
    Via Benzinga
    Esperion Therapeutics, Masimo And Other Big Stocks Moving Higher In Monday's Pre-Market Session
    U.S. stock futures were lower this morning, with the Dow futures falling by around 50 points on Monday. Shares of Esperion Therapeutics, Inc. (NASDAQ: ESPR) rose sharply in today’s pre-market trading. 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    GoodRx Interim CEO Extends Commitment to Company
    From GoodRx Holdings, Inc.
    Via Business Wire
    These Analysts Increase Their Forecasts On GoodRx Following Q4 Earnings
    GoodRx Holdings, Inc. (NASDAQ: GDRX) reported upbeat fourth-quarter FY23 results and issued first-quarter revenue guidance above estimates. 
    Via Benzinga
    Why GoodRx Stock Soared Today
    The company beat Q4 estimates, announced a new share repurchase authorization, and issued strong guidance. 
    Via The Motley Fool
    GoodRx (GDRX) Q4 2023 Earnings Call Transcript
    GDRX earnings call for the period ending December 31, 2023. 
    Via The Motley Fool
    Topics Earnings
    Exposures Financial
    Why Is Telemedicine Firm GoodRx's Shares Surging Today
    GoodRx Holdings reported strong Q4 results and issued above-estimate revenue guidance for FY24. Revenue and adjusted EBITDA increased, company also announced new stock repurchase program. 
    Via Benzinga
    GoodRx Reports Fourth Quarter and Full Year 2023 Results
    From GoodRx Holdings, Inc.
    Via Business Wire
    This healthcare stock making a buzz with 160% growth
    Healthcare stocks are typically on the boring side of the spectrum, that is until you add a bit of technology and the right niche to them. 
    Via MarketBeat
    Topics Economy
    Exposures Economy
    GoodRx to Participate in Upcoming Investor Conferences
    From GoodRx Holdings, Inc.
    Via Business Wire
    Gene therapy: Why does it cost millions for a single treatment?
    Gene therapy treatments have been making major headlines as advances in gene editing have gone mainstream thanks to the advent of CRISPR/Cas-9 technology. 
    Via MarketBeat
    Exposures Product Safety
    GoodRx Announces Date for Fourth Quarter and Full Year 2023 Earnings Release and Conference Call
    From GoodRx Holdings, Inc.
    Via Business Wire
    GoodRx Announces Proposed Refinancing of First Lien Credit Facilities
    From GoodRx Holdings, Inc.
    Via Business Wire
    The GoodRx Effect: Delivering a Transformative Impact on the U.S. Healthcare System through Prescription Savings
    From GoodRx
    Via Business Wire
    Prescription Drug Discount Provider GoodRx Expects To Build Momentum In 2024, Stock Soars
    GoodRx Holdings Inc (NASDAQ: GDRX) provided preliminary Q4 FY23 revenue of $195 million-$197 million, up 6%-7% Y/Y, versus the consensus of $190.77 million. 
    Via Benzinga
    Why WD-40 Shares Are Trading Higher By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Shares of WD-40 Company (NASDAQ: WDFC) rose sharply during Wednesday’s session after the company reported better-than-expected first-quarter results. 
    Via Benzinga
    GoodRx Announces Preliminary Fourth Quarter and Full Year 2023 Results and Early Expectations for First Quarter and Full Year 2024
    From GoodRx Holdings, Inc.
    Via Business Wire
    Election Edge: 7 Stocks to Snag Before the 2024 Presidential Race Heats Up
    Election stocks include companies at the center of national conversation and those likely to get increased government funding. 
    Via InvestorPlace
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    15 16 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.